Sigma-Aldrich signs license agreement with Polyplus-transfection for Zip Nucleic Acid (ZNA) oligonucleotides
Nov 04, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --
Company: Sigma-Aldrich Corp. (SIAL)
Sigma-Aldrich Corporation, a US-based life science company, has signed a worldwide licensing agreement with Polyplus-transfection SA, a France-based biotechnology company engaged in developing reagents for intracellular delivery of biomolecules.
According to the terms of the agreement, Sigma-Aldrich has rights to manufacture and commercialize Zip Nucleic Acid (ZNA(TM)) oligonucleotides for all research applications. ZNA provides solutions for increased affinity for nucleic acids.
Deal Type Partnership Sub-Category Commercialization,Licensing Agreement,Manufacturing Deal Status Announced: 2009-11-03
Deal Participants
Partner 1 (Company) Sigma-Aldrich Corporation Partner 2 (Company) Polyplus-transfection SA
Copyright (C) 2009 Datamonitor Financial Deals Tracker. All rights reserved
News Provided by COMTEX
Company: Sigma-Aldrich Corp. (SIAL)
Related terms: biotechnology, france, manufacturer, manufacturing, partnership
